Compare AJANTA PHARMA with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA UNICHEM LAB AJANTA PHARMA/
UNICHEM LAB
 
P/E (TTM) x 21.4 60.1 35.7% View Chart
P/BV x 3.8 0.6 584.9% View Chart
Dividend Yield % 0.9 2.1 43.5%  

Financials

 AJANTA PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
UNICHEM LAB
Mar-19
AJANTA PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,422292 487.0%   
Low Rs898182 493.2%   
Sales per share (Unadj.) Rs233.5167.7 139.3%  
Earnings per share (Unadj.) Rs44.0-3.6 -1,210.9%  
Cash flow per share (Unadj.) Rs52.25.9 877.8%  
Dividends per share (Unadj.) Rs9.004.00 225.0%  
Dividend yield (eoy) %0.81.7 46.0%  
Book value per share (Unadj.) Rs255.1372.3 68.5%  
Shares outstanding (eoy) m88.0270.38 125.1%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x5.01.4 351.4%   
Avg P/E ratio x26.4-65.3 -40.4%  
P/CF ratio (eoy) x22.239.9 55.7%  
Price / Book Value ratio x4.50.6 714.1%  
Dividend payout %20.5-110.2 -18.6%   
Avg Mkt Cap Rs m102,08116,680 612.0%   
No. of employees `0006.82.6 261.3%   
Total wages/salary Rs m4,3072,393 180.0%   
Avg. sales/employee Rs Th3,022.64,535.2 66.6%   
Avg. wages/employee Rs Th633.4919.8 68.9%   
Avg. net profit/employee Rs Th569.1-98.2 -579.5%   
INCOME DATA
Net Sales Rs m20,55411,801 174.2%  
Other income Rs m211984 21.4%   
Total revenues Rs m20,76512,785 162.4%   
Gross profit Rs m5,664-835 -678.4%  
Depreciation Rs m721674 107.0%   
Interest Rs m1275 15.4%   
Profit before tax Rs m5,143-600 -857.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273-343 -370.6%   
Profit after tax Rs m3,870-256 -1,514.4%  
Gross profit margin %27.6-7.1 -389.5%  
Effective tax rate %24.857.3 43.2%   
Net profit margin %18.8-2.2 -869.5%  
BALANCE SHEET DATA
Current assets Rs m11,81220,384 57.9%   
Current liabilities Rs m3,7765,029 75.1%   
Net working cap to sales %39.1130.1 30.0%  
Current ratio x3.14.1 77.2%  
Inventory Days Days77105 73.9%  
Debtors Days Days82135 60.5%  
Net fixed assets Rs m14,3989,023 159.6%   
Share capital Rs m175141 124.6%   
"Free" reserves Rs m22,27726,058 85.5%   
Net worth Rs m22,45226,199 85.7%   
Long term debt Rs m70-   
Total assets Rs m26,96231,496 85.6%  
Interest coverage x444.3-7.0 -6,370.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.4 203.5%   
Return on assets %14.4-0.6 -2,514.3%  
Return on equity %17.2-1.0 -1,767.1%  
Return on capital %23.0-2.0 -1,147.9%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,6828,188 130.5%   
Fx outflow Rs m2,102596 352.7%   
Net fx Rs m8,5807,592 113.0%   
CASH FLOW
From Operations Rs m3,748-3,278 -114.3%  
From Investments Rs m-2,228-2,860 77.9%  
From Financial Activity Rs m-1,475-24 6,093.4%  
Net Cashflow Rs m45-4,690 -1.0%  

Share Holding

Indian Promoters % 73.8 50.1 147.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 15.1 10.3%  
FIIs % 7.6 3.0 253.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 31.7 53.6%  
Shareholders   20,968 20,176 103.9%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   FDC LTD.  ALEMBIC LTD  WYETH LTD  DIVIS LABORATORIES  SUVEN LIFESCIENCES  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Oct 16, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS